IDENTIFICATION OF NOVEL TARGETS IN GLIOBLASTOMA STEM CELLS THROUGH CRISPR-CAS9 SCREENING

被引：0
|
作者：
Xie, Qi [1 ]
Prager, Briana [2 ]
Rich, Jeremy [2 ]
机构：
[1] Cleveland Clin, Lerner Res Inst, Dept Stem Cell Biol, Cleveland, OH 44106 USA
[2] Cleveland Clin, Lerner Res Inst, Cleveland, OH 44106 USA
来源：
NEURO-ONCOLOGY | 2017年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
STEM-13
引用
收藏
页码：228 / 229
页数：2
相关论文
共 50 条
  • [31] Applications of CRISPR-Cas9 Technology to Genome Editing in Glioblastoma Multiforme
    Al-Sammarraie, Nadia
    Ray, Swapan K.
    CELLS, 2021, 10 (09)
  • [32] Multiplexed barcoded CRISPR-Cas9 screening enabled by CombiGEM
    Wong, Alan S. L.
    Choi, Gigi C. G.
    Cui, Cheryl H.
    Pregernig, Gabriela
    Milani, Pamela
    Adam, Miriam
    Perli, Samuel D.
    Kazer, Samuel W.
    Gaillard, Aleth
    Hermann, Mario
    Shalek, Alex K.
    Fraenkel, Ernest
    Lu, Timothy K.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2016, 113 (09) : 2544 - 2549
  • [33] IDENTIFICATION OF NOVEL THERAPEUTIC TARGETS FOR GLIOBLASTOMA STEM CELLS
    Young, Sarah
    Liang, Yanping
    Murphy, Susan
    Guo, Sujuan
    Sheng, Zhi
    NEURO-ONCOLOGY, 2014, 16
  • [34] Interrogating immune cells and cancer with CRISPR-Cas9
    Buquicchio, Frank A.
    Satpathy, Ansuman T.
    TRENDS IN IMMUNOLOGY, 2021, 42 (05) : 432 - 446
  • [35] Using whole-genome CRISPR-Cas9 screening to identify resistance networks in glioblastoma.
    Budhiraja, Shreya
    Baisiwala, Shivani
    Perrault, Ella
    Chen, Li
    Park, Cheol
    Awah, Chidiebere
    Dmello, Crismita
    Zolp, Andrew
    Sonabend, Adam
    Ahmed, Atique
    CANCER RESEARCH, 2021, 81 (13)
  • [36] Genome-Wide CRISPR-Cas9 Screens Expose Genetic Vulnerabilities and Mechanisms of Temozolomide Sensitivity in Glioblastoma Stem Cells
    MacLeod, Graham
    Bozek, Danielle A.
    Rajakulendran, Nishani
    Monteiro, Vernon
    Ahmadi, Moloud
    Steinhart, Zachary
    Kushida, Michelle M.
    Yu, Helen
    Coutinho, Fiona J.
    Cavalli, Florence M. G.
    Restall, Ian
    Hao, Xiaoguang
    Hart, Traver
    Luchman, H. Artee
    Weiss, Samuel
    Dirks, Peter B.
    Angers, Stephane
    CELL REPORTS, 2019, 27 (03): : 971 - +
  • [37] CRISPR-Cas9: a promising tool for gene editing on induced pluripotent stem cells
    Kim, Eun Ji
    Kang, Ki Ho
    Ju, Ji Hyeon
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2017, 32 (01): : 42 - 61
  • [38] Trichostatin A for Efficient CRISPR-Cas9 Gene Editing of Human Pluripotent Stem Cells
    Molugu, Kaivalya
    Khajanchi, Namita
    Lazzarotto, Cicera R.
    Tsai, Shengdar Q.
    Saha, Krishanu
    CRISPR JOURNAL, 2023, 6 (05): : 473 - 485
  • [39] CRISPR-Cas9 Edited Hematopoietic Stem and Progenitor Cells for Friedreich's Ataxia
    Sivakumar, Anusha
    Rainaldi, Joseph N.
    Wan, Rita
    Rocca, Celine J.
    Cherqui, Stephanie
    MOLECULAR THERAPY, 2022, 30 (04) : 135 - 135
  • [40] Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens
    Behan, Fiona M.
    Iorio, Francesco
    Picco, Gabriele
    Goncalves, Emanuel
    Beaver, Charlotte M.
    Migliardi, Giorgia
    Santos, Rita
    Rao, Yanhua
    Sassi, Francesco
    Pinnelli, Marika
    Ansari, Rizwan
    Harper, Sarah
    Jackson, David Adam
    Mcrae, Rebecca
    Pooley, Rachel
    Wilkinson, Piers
    van der Meer, Dieudonne
    Dow, David
    Buser-Doepner, Carolyn
    Bertotti, Andrea
    Trusolino, Livio
    Stronach, Euan A.
    Saez-Rodriguez, Julio
    Yusa, Kosuke
    Garnett, Mathew J.
    NATURE, 2019, 568 (7753) : 511 - +
12345